English
Español
Français
Português
Русский
简体中文
IMCAS World Congress 2025
Speaker list
All speakers are required to follow the IMCAS Conflict of Interest Policy in order to ensure the scientific transparency and independence of the program.
The speaker list is constantly updated by our Scientific Secretariat. Come back regularly to check out the latest updates.
Iman MIR
Industry representative, Iran
“Join Me at IMCAS World Congress 2025! Excited to present "Medical Tourism: A Comprehensive Guide to Becoming a Global Leader" at IMCAS 2025! I'll be sharing insights on industry trends, key strategies, and innovations shaping global healthcare travel. 📅 Date: Saturday, 1 February 2025 📍 Room: 342 - Level 3 🕘 Time: 09:33 Don't miss this opportunity to network, learn, and explore the future of medical tourism! See you in Paris! 🌍✈️ #IMCAS2025 #MedicalTourism #GlobalHealthcare”
Dr. Bruce REITH
Plastic Surgeon, Germany
“I'm speaking at IMCAS January 30th, 2025. 14.30 - 15.30 January 31st, 2025”
Dr. Jong Seo KIM
Plastic Surgeon, South Korea
“🌟 Exciting News! 🌟 This Saturday, I’ll be in Paris at the IMCAS World Congress 2025 to present three cutting-edge topics: 1️⃣ PN Injections: Histological studies showing regeneration mechanisms through biopsy research. (The 1st stem cell study in the world for PN) CD166 & Adipogenesis: Exploring its role in increasing pre-adipocyte conversion. 2️⃣ SonoAnatomy for Filler and Thread 3️⃣ RF Treatments with Real-Time Thermal Monitoring: 3D analysis of facial lifting and temperature precision.”
Dr. Bouraoui KOTTI
Plastic Surgeon, United Arab Emirates
“Welcome dear friends and colleagues, from all over the world to the most wanted rendez vous of the year in plastic cosmetic and anti-aging medecine and surgery ! ”
Dr. Cosimo OLIVA
Gynecologist, Italy
“"AIGEF (Italian Association of Aesthetic and Functional Gynecology), proud Scientific Partner of the IMCAS World Congress, warmly invites you to join this global event, where excellence meets innovation. Represented by Dr. Elena Fasola and Dr. Cosimo Oliva, we look forward to sharing groundbreaking advancements and fostering inspiring discussions. Don’t miss this exceptional opportunity to shape the future of our field, aesthetic gynecology!" ”
Prof Jean Paul MENINGAUD
Plastic Surgeon, France
“Dear Colleagues, I am excited to announce that I will be presenting at the upcoming International Master Course on Aging Science (IMCAS) in Paris. My presentation, titled "Are Platysmal Transection and Salivary Gland Removal Necessary in Neck Lifting?", will explore the intricacies and efficacy of these surgical techniques within the context of facial rejuvenation. This session will delve into the latest advancements in lifting procedures, focusing on whether traditional approaches are still n”
Dr. Konstantinos GKRITZALAS
Cosmetic Surgeon, Greece
“ Welcome Letter Dear Colleagues, It is with great enthusiasm and honor that I welcome you to the [ IMCAS 2025 This remarkable gathering of experts, innovators, and pioneers in the field of aesthetic medicine serves as a platform for the exchange of ideas, breakthroughs, and collaborations that will shape the future of our practice. dr Konstantinos Gkritzalas Dermatologist Master Aesthetic medicine ”
Prof Maurice Y NAHABEDIAN
Plastic Surgeon, United States
“I am excited to participate with IMCAS team at the 2025 IMCAS World Congress where I will be delivering two lectures and moderating a live surgery session focused on breast surgery. This is one of the BEST conferences of the year focused on aesthetic medicine and surgery in one of the premier global venues, Paris, France. I look forward to welcoming you to this outstanding Congress! ”
Dr. Rachita DHURAT
Dermatologist, India
“Cetirizine has demonstrated inhibitory effects on prostaglandin D2 synthesis, a molecule implicated in the pathogenesis of hair follicle miniaturization in AGA. In our case series there was an increase in the hair count as compared to the baseline in 9/9 subjects post 16 weeks of therapy. The mean hair count at week 0 was 139.56 (SE of mean of 13.92) and at 16 weeks was 163.44 (SE of mean of 15.52). Cetirizine presents a potential addition to the therapeutic armamentarium for AGA.”
Something went wrong. Please try again later.
Congresses
About
Discover IMCAS Academy
Need assistance?
Discover IMCAS Academy
Need assistance?